Close Menu

NEW YORK – Bio-Rad Laboratories said after the close of the market Thursday that its third quarter revenues increased 15 percent year over year driven by COVID-19-related gains in its PCR and digital PCR businesses.

For the three months ended Sept. 30, Bio-Rad reported revenues of $647.3 million compared to $560.6 million a year ago, well ahead of analysts' average estimate of $570.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.